This site is intended for healthcare professionals only
LoginRegister
Piramal Pharma Receives USFDA EIR for Sellersville Manufacturing FacilityPiramal Pharma Receives USFDA EIR for Sellersville Manufacturing Facility
Biocon Releases New Clinical Data Backing Yesafili Biosimilar for Diabetic Macular EdemaBiocon Releases New Clinical Data Backing Yesafili Biosimilar for Diabetic Macular Edema
Novo Nordisk Brings Once-Weekly Insulin Awiqli to IndiaNovo Nordisk Brings Once-Weekly Insulin Awiqli to India
AstraZeneca Signs USD 2.1 Billion COPD Drug Licensing Deal with Sino Biopharm UnitAstraZeneca Signs USD 2.1 Billion COPD Drug Licensing Deal with Sino Biopharm Unit
Govt Committee Proposes Central Database to Identify and Ban Unapproved Drugs, FDCs from MarketGovt Committee Proposes Central Database to Identify and Ban Unapproved Drugs, FDCs from Market
Dr Reddys Delays Semaglutide Supply After API Quality IssueDr Reddy's Delays Semaglutide Supply After API Quality Issue
CDSCO Asks Pharma Firms to Update Vancomycin Labels with DRESS Syndrome ADRCDSCO Asks Pharma Firms to Update Vancomycin Labels with DRESS Syndrome ADR
Akums Maxcure Nutravedics Secures Relief from Rs 3.59 Crore Tax PenaltyAkums' Maxcure Nutravedics Secures Relief from Rs 3.59 Crore Tax Penalty
Orchid Pharma Signs USD 178 Million Russia Licensing Deal for Antibiotic ExblifepOrchid Pharma Signs USD 178 Million Russia Licensing Deal for Antibiotic Exblifep
USFDA Approves Vera Therapeutics Trutakna for Rare Kidney Disease IgA NephropathyUSFDA Approves Vera Therapeutics' Trutakna for Rare Kidney Disease IgA Nephropathy
Kaileras Oral Weight Loss Pill Delivers Up to 11.1% Weight Reduction in China StudyKailera's Oral Weight Loss Pill Delivers Up to 11.1% Weight Reduction in China Study
CDSCO Examines Use of Similar Pharma Brand Names for Different Medicines, Seeks Stakeholder FeedbackCDSCO Examines Use of Similar Pharma Brand Names for Different Medicines, Seeks Stakeholder Feedback
X